Thirteen patients with moderate to severe symptomatic BPH were treated with cetrorelix (5 mg, s.c., twice daily for 2 days followed by 1 mg/day, s.c., for 2 months) and evaluated at baseline, during treatment, and up to 18 months after therapy for effects on the International Prostate Symptom Score (IPSS), Quality of Life score, sexual function, prostate size, uroflowmetry, and hormonal levels
Where do you stand on this
Here, the TFMCs vitamin IV Lounge discusses GSHs role in skin care, getting it as an intravenous drip, and how we cater to your health goals and optimal function
Do not take within 3 hours of bedtime as it may interfere with sleep